BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Tølbøl KS, Kristiansen MN, Hansen HH, Veidal SS, Rigbolt KT, Gillum MP, Jelsing J, Vrang N, Feigh M. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. World J Gastroenterol 2018; 24(2): 179-194 [PMID: 29375204 DOI: 10.3748/wjg.v24.i2.179]
URL: https://www.wjgnet.com/1007-9327/full/v24/i2/179.htm
Number Citing Articles
1
Samuel J. Daniels, Diana J. Leeming, Sönke Detlefsen, Maria F. Bruun, Sara T. Hjuler, Kim Henriksen, Peter Hein, Morten A. Karsdal, Sarah Brockbank, Simon Cruwys. Biochemical and histological characterisation of an experimental rodent model of non-alcoholic steatohepatitis – Effects of a peroxisome proliferator-activated receptor gamma (PPAR-γ) agonist and a glucagon-like peptide-1 analogueBiomedicine & Pharmacotherapy 2019; 111: 926 doi: 10.1016/j.biopha.2018.12.130
2
Moritz Helmstädter, Jurema Schmidt, Astrid Kaiser, Lilia Weizel, Ewgenij Proschak, Daniel Merk. Differential Therapeutic Effects of FXR Activation, sEH Inhibition, and Dual FXR/sEH Modulation in NASH in Diet-Induced Obese MiceACS Pharmacology & Translational Science 2021; 4(2): 966 doi: 10.1021/acsptsci.1c00041
3
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
4
Geurt Stokman, Anita M. Hoek, Ditte Denker Thorbekk, Elsbet J. Pieterman, Sanne Skovgård Veidal, Brittany Basta, Marta Iruarrizaga‐Lejarreta, José W. Hoorn, Lars Verschuren, Jimmy F. P. Berbée, Patrick C. N. Rensen, Tore Skjæret, Cristina Alonso, Michael Feigh, John J. P. Kastelein, Scott L. Friedman, Hans M. G. Princen, David A. Fraser. Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivativeLiver International 2020; 40(11): 2860 doi: 10.1111/liv.14643
5
Thibaut Duparc, François Briand, Charlotte Trenteseaux, Jules Merian, Guillaume Combes, Souad Najib, Thierry Sulpice, Laurent O. Martinez. Liraglutide improves hepatic steatosis and metabolic dysfunctions in a 3-week dietary mouse model of nonalcoholic steatohepatitisAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 317(4): G508 doi: 10.1152/ajpgi.00139.2019
6
Maria N. B. Kristiansen, Sanne S. Veidal, Christina Christoffersen, Jacob Jelsing, Kristoffer T. G. Rigbolt. Molecular Characterization of Microvesicular and Macrovesicular Steatosis Shows Widespread Differences in Metabolic PathwaysLipids 2019;  doi: 10.1002/lipd.12121
7
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASHScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
8
Kristiaan Wouters, Alessia S. Cento, Katrien H. Gaens, Margee Teunissen, Jean L. J. M. Scheijen, Federica Barutta, Fausto Chiazza, Debora Collotta, Manuela Aragno, Gabriella Gruden, Massimo Collino, Casper G. Schalkwijk, Raffaella Mastrocola. Deletion of RAGE fails to prevent hepatosteatosis in obese mice due to impairment of other AGEs receptors and detoxifying systemsScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-96859-7
9
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitisDiabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
10
Mette Simone Aae Madsen, Jacob Bak Holm, Albert Pallejà, Pernille Wismann, Katrine Fabricius, Kristoffer Rigbolt, Martin Mikkelsen, Morten Sommer, Jacob Jelsing, Henrik Bjørn Nielsen, Niels Vrang, Henrik H. Hansen. Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese miceScientific Reports 2019; 9(1) doi: 10.1038/s41598-019-52103-x
11
Marcos Antonio Ferreira, Hatylas Azevedo, Alessandra Mascarello, Natanael Dante Segretti, Elisa Russo, Valter Russo, Cristiano Ruch Werneck Guimarães. Discovery of ACH-000143: A Novel Potent and Peripherally Preferred Melatonin Receptor Agonist that Reduces Liver Triglycerides and Steatosis in Diet-Induced Obese RatsJournal of Medicinal Chemistry 2021; 64(4): 1904 doi: 10.1021/acs.jmedchem.0c00627
12
Ludovico Abenavoli, Tetyana Falalyeyeva, Luigi Boccuto, Olena Tsyryuk, Nazarii Kobyliak. Obeticholic Acid: A New Era in the Treatment of Nonalcoholic Fatty Liver DiseasePharmaceuticals 2018; 11(4): 104 doi: 10.3390/ph11040104
13
Qian-Nan Di, Wei-Xin Cao, Run Xu, Lingeng Lu, Qian Xu, Xiao-Bin Wang. Chronic low-dose exposure of nonylphenol alters energy homeostasis in the reproductive system of female ratsToxicology and Applied Pharmacology 2018; 348: 67 doi: 10.1016/j.taap.2018.04.007
14
Sanja Stojsavljevic-Shapeski, Marko Duvnjak, Lucija Virovic-Jukic, Davor Hrabar, Lea Smircic Duvnjak. New Drugs on the Block—Emerging Treatments for Nonalcoholic SteatohepatitisJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00057
15
Pascale Gluais‐Dagorn, Marc Foretz, Gregory R. Steinberg, Battsetseg Batchuluun, Anna Zawistowska‐Deniziak, Joost M. Lambooij, Bruno Guigas, David Carling, Pierre‐Axel Monternier, David E. Moller, Sebastien Bolze, Sophie Hallakou‐Bozec. Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis Hepatology Communications 2021;  doi: 10.1002/hep4.1799
16
Eloy D. Hernandez, Lianxing Zheng, Young Kim, Bin Fang, Bo Liu, Reginald A. Valdez, William F. Dietrich, Paul V. Rucker, Donatella Chianelli, James Schmeits, Dingjiu Bao, Jocelyn Zoll, Claire Dubois, Glenn C. Federe, Lihao Chen, Sean B. Joseph, Lloyd B. Klickstein, John Walker, Valentina Molteni, Peter McNamara, Shelly Meeusen, David C. Tully, Michael K. Badman, Jie Xu, Bryan Laffitte. Tropifexor‐Mediated Abrogation of Steatohepatitis and Fibrosis Is Associated With the Antioxidative Gene Expression Profile in RodentsHepatology Communications 2019; 3(8): 1085 doi: 10.1002/hep4.1368
17
Anita M. van den Hoek, Lars Verschuren, Nicole Worms, Anita van Nieuwkoop, Christa de Ruiter, Joline Attema, Aswin L. Menke, Martien P. M. Caspers, Sridhar Radhakrishnan, Kanita Salic, Robert Kleemann. A Translational Mouse Model for NASH with Advanced Fibrosis and Atherosclerosis Expressing Key Pathways of Human PathologyCells 2020; 9(9): 2014 doi: 10.3390/cells9092014
18
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating PeptidesFrontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
19
Danny Orabi, Nathan A. Berger, J. Mark Brown. Abnormal Metabolism in the Progression of Nonalcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Mechanistic Insights to ChemopreventionCancers 2021; 13(14): 3473 doi: 10.3390/cancers13143473
20
Sarah Lechner, Matthew Yee, Berkeley N. Limketkai, Edward A. Pham. Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future DirectionDigestive Diseases and Sciences 2020; 65(3): 897 doi: 10.1007/s10620-020-06100-0
21
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitisBMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
22
Victoria S. Jensen, Pernille Tveden-Nyborg, Christina Zacho-Rasmussen, Michelle L. Quaade, David H. Ipsen, Henning Hvid, Christian Fledelius, Erik M. Wulff, Jens Lykkesfeldt. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent modelsJournal of Pharmacological and Toxicological Methods 2020; 101: 106651 doi: 10.1016/j.vascn.2019.106651
23
Hyunmi Kim, Da Som Lee, Tae Hyeon An, Hyun-Ju Park, Won Kon Kim, Kwang-Hee Bae, Kyoung-Jin Oh. Metabolic Spectrum of Liver Failure in Type 2 Diabetes and Obesity: From NAFLD to NASH to HCCInternational Journal of Molecular Sciences 2021; 22(9): 4495 doi: 10.3390/ijms22094495
24
Daniel Ferguson, Brian N. Finck. Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitusNature Reviews Endocrinology 2021; 17(8): 484 doi: 10.1038/s41574-021-00507-z
25
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver StudiesJournal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14
26
Jose Cordoba-Chacon. Loss of Hepatocyte-Specific PPARγ Expression Ameliorates Early Events of Steatohepatitis in Mice Fed the Methionine and Choline-Deficient DietPPAR Research 2020; 2020: 1 doi: 10.1155/2020/9735083
27
Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros. The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic SteatohepatitisHepatology Communications 2020; 4(9): 1302 doi: 10.1002/hep4.1558
28
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease2019; : 369 doi: 10.1007/978-3-030-11748-1_14
29
Joseph Yi Zhou, Anil Poudel, Ryan Welchko, Naveen Mekala, Prashanth Chandramani-Shivalingappa, Mariana Georgeta Rosca, Lixin Li. Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathwaysEuropean Journal of Pharmacology 2019; 861: 172594 doi: 10.1016/j.ejphar.2019.172594
30
Pankaj Aggarwal, Tamneet Singh, Naim Alkhouri. Metabolic Targets in Nonalcoholic Steatohepatitis: Treating the Disease at the Metabolic RootCurrent Hepatology Reports 2020; 19(3): 302 doi: 10.1007/s11901-020-00533-x
31
François Briand, Christophe Heymes, Lucile Bonada, Thibault Angles, Julie Charpentier, Maxime Branchereau, Emmanuel Brousseau, Marjolaine Quinsat, Nicolas Fazilleau, Rémy Burcelin, Thierry Sulpice. A 3‐week nonalcoholic steatohepatitis mouse model shows elafibranor benefits on hepatic inflammation and cell deathClinical and Translational Science 2020; 13(3): 529 doi: 10.1111/cts.12735
32
Suling Huang, Yanwei Wu, Zhuohui Zhao, Bing Wu, Kai Sun, Haoyu Wang, Li Qin, Fang Bai, Ying Leng, Wei Tang. A new mechanism of obeticholic acid on NASH treatment by inhibiting NLRP3 inflammasome activation in macrophageMetabolism 2021; 120: 154797 doi: 10.1016/j.metabol.2021.154797
33
Pascal Heitel, Giuseppe Faudone, Moritz Helmstädter, Jurema Schmidt, Astrid Kaiser, Amelie Tjaden, Martin Schröder, Susanne Müller, Simone Schierle, Julius Pollinger, Daniel Merk. A triple farnesoid X receptor and peroxisome proliferator-activated receptor α/δ activator reverses hepatic fibrosis in diet-induced NASH in miceCommunications Chemistry 2020; 3(1) doi: 10.1038/s42004-020-00411-z
34
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza Potes. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver DiseaseNutrients 2019; 11(12): 2871 doi: 10.3390/nu11122871
35
David H Ipsen, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?Advances in Nutrition 2020; 11(6): 1696 doi: 10.1093/advances/nmaa081
36
Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga. Investigating fibrosis and inflammation in an ex vivo NASH murine modelAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2020; 318(2): G336 doi: 10.1152/ajpgi.00209.2019
37
Daniel Lindén, Andrea Ahnmark, Piero Pingitore, Ester Ciociola, Ingela Ahlstedt, Anne-Christine Andréasson, Kavitha Sasidharan, Katja Madeyski-Bengtson, Magdalena Zurek, Rosellina M. Mancina, Anna Lindblom, Mikael Bjursell, Gerhard Böttcher, Marcus Ståhlman, Mohammad Bohlooly-Y, William G. Haynes, Björn Carlsson, Mark Graham, Richard Lee, Sue Murray, Luca Valenti, Sanjay Bhanot, Peter Åkerblad, Stefano Romeo. Pnpla3 silencing with antisense oligonucleotides ameliorates nonalcoholic steatohepatitis and fibrosis in Pnpla3 I148M knock-in miceMolecular Metabolism 2019; 22: 49 doi: 10.1016/j.molmet.2019.01.013
38
Anita M. van den Hoek, Lars Verschuren, Martien P. M. Caspers, Nicole Worms, Aswin L. Menke, Hans M. G. Princen. Beneficial effects of elafibranor on NASH in E3L.CETP mice and differences between mice and menScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83974-8
39
Maria Lucey, Philip Pickford, Stavroula Bitsi, James Minnion, Jan Ungewiss, Katja Schoeneberg, Guy A. Rutter, Stephen R. Bloom, Alejandra Tomas, Ben Jones. Disconnect between signalling potency and in vivo efficacy of pharmacokinetically optimised biased glucagon-like peptide-1 receptor agonistsMolecular Metabolism 2020; 37: 100991 doi: 10.1016/j.molmet.2020.100991
40
Vasiliki Venetsanaki, Zacharoula Karabouta, Stergios A. Polyzos. Farnesoid X nuclear receptor agonists for the treatment of nonalcoholic steatohepatitisEuropean Journal of Pharmacology 2019; 863: 172661 doi: 10.1016/j.ejphar.2019.172661
41
Martine C. Morrison, Lars Verschuren, Kanita Salic, Joanne Verheij, Aswin Menke, Peter Y. Wielinga, Marta Iruarrizaga‐Lejarreta, Laurent Gole, Wei‐Miao Yu, Scott Turner, Martien P.M. Caspers, Ibon Martínez‐Arranz, Elsbet Pieterman, Reinout Stoop, Arianne van Koppen, Anita M. van den Hoek, José M. Mato, Roeland Hanemaaijer, Cristina Alonso, Robert Kleemann. Obeticholic Acid Modulates Serum Metabolites and Gene Signatures Characteristic of Human NASH and Attenuates Inflammation and Fibrosis Progression in Ldlr‐/‐.Leiden MiceHepatology Communications 2018; 2(12): 1513 doi: 10.1002/hep4.1270
42
Bader Zarrouki, Jeremie Boucher. Kupffer CellsMethods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
43
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic SteatohepatitisDigestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
44
Wen-Cong Li, Su-Xian Zhao, Wei-Guang Ren, Yu-Guo Zhang, Rong-Qi Wang, Ling-Bo Kong, Qing-Shan Zhang, Yue-Min Nan. Co‑administration of obeticholic acid and simvastatin protects against high‑fat diet‑induced non‑alcoholic steatohepatitis in miceExperimental and Therapeutic Medicine 2021; 22(2) doi: 10.3892/etm.2021.10262
45
Guodong Zhang, Xiaoli Wang, Tzu-Yang Chung, Weiwei Ye, Lauren Hodge, Likun Zhang, Keefe Chng, Yong-Fu Xiao, Yixin Jim Wang. Carbon tetrachloride (CCl4) accelerated development of non-alcoholic fatty liver disease (NAFLD)/steatohepatitis (NASH) in MS-NASH mice fed western diet supplemented with fructose (WDF)BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01467-w
46
Anne Fougerat, Alexandra Montagner, Nicolas Loiseau, Hervé Guillou, Walter Wahli. Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver DiseaseCells 2020; 9(7): 1638 doi: 10.3390/cells9071638
47
Piero Pingitore, Kavitha Sasidharan, Matias Ekstrand, Sebastian Prill, Daniel Lindén, Stefano Romeo. Human Multilineage 3D Spheroids as a Model of Liver Steatosis and FibrosisInternational Journal of Molecular Sciences 2019; 20(7): 1629 doi: 10.3390/ijms20071629
48
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat sourceWorld Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
49
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASHBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
50
Monica Gomaraschi, Anna Ludovica Fracanzani, Paola Dongiovanni, Chiara Pavanello, Eleonora Giorgio, Lorenzo Da Dalt, Giuseppe Danilo Norata, Laura Calabresi, Dario Consonni, Rosa Lombardi, Adriana Branchi, Silvia Fargion. Lipid accumulation impairs lysosomal acid lipase activity in hepatocytes: Evidence in NAFLD patients and cell culturesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2019; 1864(12): 158523 doi: 10.1016/j.bbalip.2019.158523
51
Nikolaos Perakakis, Konstantinos Stefanakis, Michael Feigh, Sanne S. Veidal, Christos S. Mantzoros. Elafibranor and liraglutide improve differentially liver health and metabolism in a mouse model of non‐alcoholic steatohepatitisLiver International 2021; 41(8): 1853 doi: 10.1111/liv.14888
52
Phil Pickford, Maria Lucey, Roxana-Maria Rujan, Emma Rose McGlone, Stavroula Bitsi, Fiona B. Ashford, Ivan R. Corrêa, David J. Hodson, Alejandra Tomas, Giuseppe Deganutti, Christopher A. Reynolds, Bryn M. Owen, Tricia M. Tan, James Minnion, Ben Jones, Stephen R. Bloom. Partial agonism improves the anti-hyperglycaemic efficacy of an oxyntomodulin-derived GLP-1R/GCGR co-agonistMolecular Metabolism 2021; 51: 101242 doi: 10.1016/j.molmet.2021.101242
53
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
54
Ivan Linares, Matyas Hamar, Nazia Selzner, Markus Selzner. Steatosis in Liver Transplantation: Current Limitations and Future StrategiesTransplantation 2019; 103(1): 78 doi: 10.1097/TP.0000000000002466
55
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructoseBMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
56
Aimo Kannt, Paulus Wohlfart, Andreas Nygaard Madsen, Sanne Skovgård Veidal, Michael Feigh, Dieter Schmoll. Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosisBritish Journal of Pharmacology 2021; 178(12): 2412 doi: 10.1111/bph.15427